Fast platelet suppression by lysine acetylsalicylate in chronic stable coronary patients. Potential clinical impact over regular aspirin for coronary syndromes

Abstract

Platelet aggregation inhibition immediately following LA may have significant clinical implications for the treatment of coronary syndromes.